Biovie Inc. SEC filings BIVI
Biovie Inc. has 507 filings in SEC EDGAR's recent list, going back to Jul 2, 2013. Its latest annual report, Form 10-K, was filed on Aug 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 11, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Sep 28, 2026 | Sep 28, 2026 |
| DEF 14A | Proxy statement | Sep 25, 2025 | Sep 25, 2025 |
| DEF 14A | Proxy statement | Jun 2, 2025 | Jun 2, 2025 |
| PRE 14A | Preliminary proxy statement | May 8, 2025 | May 8, 2025 |
| PRE 14C | Filing | May 7, 2025 | May 7, 2025 |
| DEFA14A | Additional proxy material | Oct 22, 2024 | — |
| DEF 14A | Proxy statement | Sep 27, 2024 | Sep 27, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 17, 2024 | Sep 17, 2024 |
| DEF 14A | Proxy statement | Jun 17, 2024 | Jun 17, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 7, 2024 | Jun 7, 2024 |
| DEF 14A | Proxy statement | Sep 29, 2023 | Sep 29, 2023 |
| DEF 14A | Proxy statement | Sep 30, 2022 | Sep 30, 2022 |
| DEF 14C | Information statement | Jul 25, 2022 | Jul 25, 2022 |
| PRE 14C | Filing | Jul 15, 2022 | Jul 15, 2022 |
| DEF 14A | Proxy statement | Sep 14, 2021 | Sep 13, 2021 |
| DEF 14C | Information statement | May 8, 2019 | May 8, 2019 |
| PRE 14C | Filing | Apr 29, 2019 | Apr 29, 2019 |
| DEF 14C | Information statement | Jul 13, 2018 | Jul 13, 2018 |
| PRE 14C | Filing | Jul 3, 2018 | Jul 3, 2018 |
| DEF 14A | Proxy statement | Jul 1, 2016 | Jul 1, 2016 |
| PRE 14A | Preliminary proxy statement | Jun 8, 2016 | Jun 7, 2016 |
| PRE 14C | Filing | Apr 21, 2016 | Apr 19, 2016 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BIVI (Nasdaq), BIVIW (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Carson City, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1580149
- Former names
- NANOANTIBIOTICS, INC. (until Jul 22, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.